Central Venous Catheter-related Complications in Patients Under Anticancer Treatment

Centre Hospitalier Alpes Leman100 enrolled

Overview

Oncology and hemotology patients under anticancer treatments are exposed to increased risks of central venous catheter-related complications due to the underlying cancer and its treament. This prospective observational monocentric french study aims at describing the incidence of such complications, their morbimortality, and analyzing some risk factors in order to contribute to propose some strategies to reduce these complications' rate and consequences

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Central Venous Catheter Thrombosis Central Venous Catheter Related Bloodstream Infection Solid Tumor Hematologic Malignancy

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: All patients older than 18 years, with solid cancer or hematological malignancy receiving anticancer treatment in the outpatient medical department of Alpes Leman Hospital and having a central venous catheter been placed between the 11th of July 2022, and the 1st of January 2023.

Outcomes

Primary Outcomes

Incidence rate and density of central venous catheter-related complications (infections, thromboses, extravasation)

Time frame: 6 months

Secondary Outcomes

Incidence rate of severe central venous catheter-related complications